Biogen CEO Chris Viehbacher on 2026 drug pipeline outlook, rare disease strategy

Biogen CEO Chris Viehbacher joins ‘Squawk Box’ to discuss the company’s 2026 outlook, drug pipeline, the focus on rare diseases, state of the biotech sector, and more.